Delivery Order SPE2DB25D3012-SPE2DB25FXAHC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,844.50 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 1.25 mcg inhalation solution (4 gm). This competitively awarded, firm fixed-price contract has a completion date of June 11, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order valued at $1,322.94 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4 grams) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,158.44 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhalation medication in 4-gram units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military...
- The Defense Logistics Agency awarded a delivery order valued at $2,780.40 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 1.25 mcg inhalation medication in 4-gram quantities. This non-set-aside, firm fixed price delivery order was competitively awarded and has an ultimate completion date of August 19, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,429.73 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation solution (4 grams) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $5,790.98 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4 gram quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Spiriva Respimat 2.5 mcg inhaler (4 grams) with a ceiling value of $1,629.61. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract is scheduled for completion by September 15, 2025, with fulfillment from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $7,413.38 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation medication (4 gram formulation) on September 11, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,917.50 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation medication (4 grams) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $10,198.57 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4 gm quantities. This non-compete, firm fixed-price delivery order was issued on July 14, 2025, with an ultimate completion date of July 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXAHCDelivery Order
The Defense Logistics Agency awarded a $3,470.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Spiriva Respimat 1.25 mcg inhalation medication in 4-gram quantities. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), was competitively awarded with no set-aside designation. Performance will be completed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a prime vendor under the DLA Troop Support Medical contract, the company supplies a comprehensive portfolio of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This delivery order represents routine pharmaceutical fulfillment under the company's established prime vendor relationship with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 9/18/25 |